Randal D'hondt

Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes.

M. André, K. van Eygen, W. Pluymers, 2014, Leukemia research.

Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer

H. Denys, C. Vulsteke, N. Ben-Baruch, 2020, Breast Cancer Research and Treatment.

Safety and efficacy of weekly docetaxel in frail and/or elderly patients with metastatic breast cancer: a phase II study

R. Paridaens, H. Wildiers, A. V. van Oosterom, 2004, Anti-cancer drugs.